Bank Of Montreal Novavax Inc Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Novavax Inc stock. As of the latest transaction made, Bank Of Montreal holds 2,454,325 shares of NVAX stock, worth $19.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,454,325

Previous 2,035,398 20.58%

Holding current value

$19.8 Million

Previous $25.8 Million 20.3%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $4.49 Million - $7.17 Million	418,927 Added 20.58%	2,454,325 $31 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $5.35 Million - $28.8 Million	1,375,047 Added 208.23%	2,035,398 $25.8 Million
Q1 2024 May 13, 2024	SELL	$3.76 - $6.02 $734,726 - $1.18 Million	-195,406 Reduced 22.83%	660,351 $3.16 Million
Q4 2023 Feb 08, 2024	BUY	$4.8 - $7.67 $4.11 Million - $6.56 Million	855,757 New	855,757 $4.11 Million
Q2 2023 Aug 02, 2023	BUY	$6.67 - $9.52 $120,933 - $172,607	18,131 New	18,131 $134,000
Q1 2023 Jun 13, 2024	SELL	$5.76 - $12.48 $3.7 Million - $8.02 Million	-642,633 Reduced 97.32%	17,718 $122,000
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $33,306 - $139,299	1,830 Added 1.37%	135,118 $2.63 Million
Q2 2022 Aug 11, 2022	BUY	$36.28 - $75.29 $4.52 Million - $9.39 Million	124,666 Added 1445.91%	133,288 $7.07 Million
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $1.55 Million - $3.17 Million	-22,208 Reduced 72.03%	8,622 $685,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $1.71 Million - $2.77 Million	-12,688 Reduced 29.16%	30,830 $4.83 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $2.58 Million - $3.93 Million	-14,518 Reduced 25.02%	43,518 $8.86 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $7.02 Million - $15 Million	58,036 New	58,036 $12.1 Million

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account